Inflammation
Pau d'Arco and Inflammation
Important disclaimer
This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Pau d'Arco is not intended to diagnose, treat, cure, or prevent any disease. We summarize published research and traditional use — this is not a recommendation to use Pau d'Arco for any specific condition. Always consult a qualified healthcare professional before starting a new supplement, especially alongside an existing medical condition or medication.
Acute inflammation is a protective immune response; chronic inflammation is increasingly linked to conditions from osteoarthritis to inflammatory bowel disease. Pau d'Arco (Tabebuia impetiginosa) has a long traditional history of use for fevers, infections, and joint pain, and modern research has looked at specific mechanisms behind that use. As with the rest of this site, mechanism research and a treatment claim are two different things — this article keeps them separate.
The Chemical Basis: Naphthoquinones and Quercetin
Pau d'Arco's anti-inflammatory research centers on its naphthoquinones (lapachol, beta-lapachone) alongside quercetin, a well-studied antioxidant flavonoid. Lab research describes a "multi-targeted" effect on inflammatory signaling, rather than blocking a single enzyme the way many pharmaceutical anti-inflammatories do.
Prostaglandin and COX-2 Research
A study using water-based Pau d'Arco extracts found significant inhibition of prostaglandin production — the hormone-like substances that mediate pain, fever, and swelling — reportedly by suppressing the COX-2 enzyme, the same target as many NSAIDs. This is an extract study, not a human trial, and it doesn't mean Pau d'Arco tea works like or replaces an NSAID; talk to a doctor about managing diagnosed pain or inflammation.
Source: Journal of Ethnopharmacology (2008)
A 2020 review in Phytochemistry also discussed beta-lapachone's role in animal models of inflammatory bowel disease and asthma, reporting lower pro-inflammatory markers — again, animal-model evidence.
NF-κB and Cytokine Suppression
At the center of the inflammatory response is NF-κB, a protein complex that, when activated, switches on genes producing pro-inflammatory cytokines like TNF-alpha and IL-6.
Pau d'Arco extracts have been reported to block the NF-κB and AP-1 signaling pathways in lab research. This immunomodulatory mechanism — shifting the balance of pro- and anti-inflammatory signaling rather than broadly suppressing the immune system — shows up across several of this site's topics, including gut balance, cancer-related inflammatory pathways, and Candida.
Source: Mediators of Inflammation (2017)
Joint and Cartilage Research
Research on matrix metalloproteinases (MMP2, MMP9, MMP13) — enzymes responsible for cartilage breakdown in osteoarthritis — has reported reduced MMP activity with Pau d'Arco extract exposure, alongside antioxidant protection of synovial tissue in lab models. This is cell/tissue-model research, not a clinical trial in people with osteoarthritis.
Source: Journal of Functional Foods (2021)
The Decoction Method
The active compounds aren't highly water-soluble, so a simple infusion under-extracts them:
- 3 tablespoons of high-quality inner bark (fine grind) per 4½ cups of water, in a glass or stainless steel pot.
- Bring to a boil, then reduce heat, cover, and simmer 25 minutes.
- Strain through a fine mesh filter.
- Traditional-use guidance is generally 1–2 cups daily, up to 3–4 for more intensive support, adjusted for tolerance.
We follow this same method for Taheebo Wellness Tea — see our FAQ for more on dosage and sourcing.
Precautions and Considerations
- Pregnancy and breastfeeding: avoid — isolated lapachol has shown abortifacient properties in animal studies; no human safety data confirms whole-bark tea is different.
- Blood-thinning effects: consult a doctor if on prescription blood thinners or scheduled for surgery.
- GI sensitivity: high doses may cause mild nausea; reduce dose or take with food.
- Quality control: use inner bark of Tabebuia impetiginosa/avellanedae — see our sourcing guide.
Where This Leaves Us
The mechanism research on Pau d'Arco and inflammation spans a real range — COX-2, NF-κB, MMP enzymes — but nearly all of it sits at the lab or animal-model tier. If you're managing a diagnosed inflammatory condition, this is background reading, not a treatment plan; that conversation belongs with your healthcare provider.
References
- 1.Journal of Ethnopharmacology (2008): "Anti-inflammatory and antinociceptive activities of the bark extract of Tabebuia avellanedae."
- 2.Molecules (2020): "Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties."
- 3.Phytochemistry (2021): "Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis."
- 4.Mediators of Inflammation (2017): NF-κB and AP-1 pathway inhibition research.
- 5.Journal of Functional Foods (2021): Antioxidant polyphenol research on synovial tissue.